Rosett Max
Chief Financial Officer
Rosett Max has filed 3 SEC Form 4 filings (7 transaction rows) across 1 company, with disclosures dating back to 2026. 3 of those filings fall inside the rolling window. Most recent filing: Jul 27, 2026.
On the most recent filing, Rosett Max is listed as Chief Financial Officer at Immunome Inc. Inside the rolling window, Rosett Max reported no open-market purchases and 2 open-market sales totaling $2.5M in IMNM. The largest disclosed transaction in the window is a sale of 65,000 IMNM shares on Apr 2, 2026, worth $1.4M.
Companies traded
Other insiders at IMNM
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$2.5M
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Rosett Max made?
Rosett Max has filed 3 SEC Form 4 filings (7 transaction rows) across 1 company since 2026.
Which companies does Rosett Max trade?
Rosett Max has filed SEC Form 4 disclosures for 1 company, including IMNM.
When was Rosett Max's most recent SEC Form 4 filing?
Rosett Max's most recent SEC Form 4 filing on Tracefour is dated Jul 27, 2026.
What is Rosett Max's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Rosett Max is listed as Chief Financial Officer.
What is Rosett Max's total buy and sell value in the current window?
Inside the rolling retention window, Rosett Max bought $0 and sold $2.5M based on SEC Form 4 filings.
What was Rosett Max's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 65,000 IMNM shares on 2026-04-02, worth $1.4M, per SEC Form 4 filings.